Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease

…, CJ White, PG Gibson, R WoodBaker… - Cochrane Database …, 2014 - cochranelibrary.com
Background Acute exacerbations of chronic obstructive pulmonary disease (COPD) are a
major cause of hospital admission and mortality. They contribute to long‐term decline in lung …

Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial

…, KE Wills, L Blizzard, EH Walters, R Wood-Baker - Bmj, 2010 - bmj.com
Objectives To compare standard high flow oxygen treatment with titrated oxygen treatment
for patients with an acute exacerbation of chronic obstructive pulmonary disease in the …

Influenza vaccine for patients with chronic obstructive pulmonary disease

P Poole, EE Chacko, R WoodBaker… - Cochrane Database of …, 2006 - cochranelibrary.com
Background Influenza vaccinations are currently recommended in the care of people with
COPD, but these recommendations are based largely on evidence from observational studies …

Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life

…, I Feather, KJ Allen, R Wood-Baker… - The lancet Respiratory …, 2018 - thelancet.com
Background Lifetime lung function is related to quality of life and longevity. Over the lifespan,
individuals follow different lung function trajectories. Identification of these trajectories, their …

Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive …

…, C Ward, S Weston, HK Muller, R WOODBAKER… - …, 2010 - Wiley Online Library
Background and objective: In COPD, the airways are chronically inflamed, and we have now
observed fragmentation of the reticular basement membrane (Rbm). This appears to be a …

Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease

…, DJ Tan, CJ White, R WoodBaker - Cochrane Database of …, 2018 - cochranelibrary.com
Background Current guidelines recommend that patients with acute exacerbations of chronic
obstructive pulmonary disease (COPD) should be treated with systemic corticosteroid for …

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease

…, P Poole, RH Granger, R WoodBaker - Cochrane Database …, 2010 - cochranelibrary.com
Background As chronic obstructive pulmonary disease (COPD) progresses, exacerbations
can occur with increasing frequency. One goal of therapy is to prevent these exacerbations, …

Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study

…, CV Senaratna, NS Idrose, RR Wood-Baker… - The Lancet …, 2023 - thelancet.com
Background Interest in lifetime lung function trajectories has increased in the context of
emerging evidence that chronic obstructive pulmonary disease (COPD) can arise from multiple …

Cardioselective beta‐blockers for reversible airway disease

…, EE Salpeter, R WoodBaker… - Cochrane Database …, 1996 - cochranelibrary.com
Background Beta‐blocker therapy has mortality benefit in patients with hypertension, heart
failure and coronary artery disease, as well as during the perioperative period. These drugs …

Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease

…, JNQ Tang, P Poole, R WoodBaker - Cochrane Database …, 2017 - cochranelibrary.com
Background People with chronic obstructive pulmonary disease (COPD) are at increased
risk of pneumococcal disease, especially pneumonia, as well as acute exacerbations with …